Bank of New York Mellon’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.6M Buy
436,020
+184,873
+74% +$5.79M ﹤0.01% 1724
2025
Q1
$8.43M Buy
251,147
+204,550
+439% +$6.86M ﹤0.01% 1931
2024
Q4
$1.83M Sell
46,597
-2,294
-5% -$89.9K ﹤0.01% 2780
2024
Q3
$1.92M Sell
48,891
-2,363
-5% -$93K ﹤0.01% 2754
2024
Q2
$2M Sell
51,254
-15,656
-23% -$610K ﹤0.01% 2792
2024
Q1
$2.88M Buy
66,910
+251
+0.4% +$10.8K ﹤0.01% 2574
2023
Q4
$3.07M Sell
66,659
-100,690
-60% -$4.64M ﹤0.01% 2608
2023
Q3
$5.72M Sell
167,349
-44,392
-21% -$1.52M ﹤0.01% 2243
2023
Q2
$8.15M Buy
211,741
+12,354
+6% +$476K ﹤0.01% 2050
2023
Q1
$7.14M Sell
199,387
-188,973
-49% -$6.76M ﹤0.01% 2108
2022
Q4
$15.3M Sell
388,360
-49,285
-11% -$1.94M ﹤0.01% 1692
2022
Q3
$15.8M Sell
437,645
-125,542
-22% -$4.53M ﹤0.01% 1634
2022
Q2
$17.1M Sell
563,187
-16,021
-3% -$487K ﹤0.01% 1622
2022
Q1
$17.7M Sell
579,208
-212,317
-27% -$6.49M ﹤0.01% 1743
2021
Q4
$24.7M Sell
791,525
-143,118
-15% -$4.47M ﹤0.01% 1594
2021
Q3
$14.3M Sell
934,643
-899
-0.1% -$13.7K ﹤0.01% 1919
2021
Q2
$17.4M Sell
935,542
-22,611
-2% -$421K ﹤0.01% 1811
2021
Q1
$17.2M Buy
958,153
+8,915
+0.9% +$160K ﹤0.01% 1788
2020
Q4
$14.6M Buy
949,238
+202,435
+27% +$3.11M ﹤0.01% 1804
2020
Q3
$8.27M Sell
746,803
-47,886
-6% -$530K ﹤0.01% 1955
2020
Q2
$9.97M Buy
794,689
+118,813
+18% +$1.49M ﹤0.01% 1844
2020
Q1
$7.66M Buy
675,876
+429,613
+174% +$4.87M ﹤0.01% 1847
2019
Q4
$3.23M Sell
246,263
-3,987
-2% -$52.3K ﹤0.01% 2567
2019
Q3
$2.26M Buy
250,250
+22,711
+10% +$205K ﹤0.01% 2685
2019
Q2
$2.24M Buy
+227,539
New +$2.24M ﹤0.01% 2738